2 online
 
Change language:    
Menu

4202011_email_gmail_mail_logo_social_icon.png  4102573_applications_facebook_media_social_icon.png  11244080_x_twitter_elon_musk_twitter_new_logo_icon.png  5296501_linkedin_network_linkedin_logo_icon.png  386762_youtube_video_you_tube_icon.png


Vyhledávání v abstraktech

Sponzor



PROHLÍŽENÍ ABSTRAKTA

EZETIMIB MONOTHERAPY IN PATIENTS WITH STATIN INTOLERANCE - FIRST CLINICAL EXPERIENCE
Tématický okruh:
Typ: Ústní sdělení - lékařské , Číslo v programu: 25

Šišáková M.1, Špinar J.2

1 I. Interní klinika, FN Brno Bohunice, Brno, 2 I. Interní klinika, FN Brno, Brno


Introduction: Ezetimib is a new drug used in dislipidemic patients, mostly used in combination with statins. We observed successful ezetimib monotherapy in patients with side effects during statin treatment.

Patients and  methods: In three patients, in which simvastatin or atorvastatin monotherapy was interrrupted due to laboratory pathology (elevation of creatininkinase – CK, ALT and AST) was ezetimib monotherapy started. In all of these patients control laboratory tests showed lowering of cholesterol and triglyceride levels and also lowering of CK, ALT and AST. No new side effects during ezetimibe treatmend occured. Detailed data will be presented.

Conclusion: Ezetimib monotherapy in patients with statin side effects is well tolerated and regression in pathological laboratory tests was observed. No new side effects occured.